510(k) · Cleared
ClearedCianna Medical Tissue Marker and Delivery System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cianna Medical · PBY Temporary Tissue Marker
Cleared on Feb 4, 2013 as substantially equivalent to K102506 (Cortex Manufacturing, Inc., 2011) and 2 other predicates after a 325-day review. Its family tree reaches back 6 generations to 2003. 15 later devices descend from it.
- Decided
- Feb 4, 2013
- Review
- 325 days
- Class
- Class II
- Product code
- PBY
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 6 generations to K023694 (2003). 20 ancestors in all, the oldest K970817 (1997). 15 later devices descend from it, 2 citing it directly.
- Root · 6 generations backK023694 Bio-Mark Resorbable Biopsy Site Marker and Bio-Mark Permanent Biopsy…Biopsy Sciences, LLC · 2003
- 5 generations backK051421 Inter V Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc. · 2005
- 4 generations backK053518 Interv Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc. · 2006
- 3 generations backK060769 Hydromark Biopsy Site MarkerBiopsy Sciences, LLC · 2006
- 2 generations backK083006 Biopsy Sciences, Inc., Hydromark Breast Biopsy Site MarkerBiopsy Sciences, LLC · 2009
- 1 generation backK090501 Biopsy Sciences Hydromark Breast Biopsy Site Marker, Models…Biopsy Sciences, LLC · 2009
- This deviceK120804 Cianna Medical Tissue Marker and Delivery SystemCianna Medical · 2013
- Descendant · cites it directly · 13 of its ownK153044 Sentimag System, Sentimark Magnetic Marker SystermEndomagnetics Ltd., · 2016
- Descendant · 2 generations on · 12 of its ownK163541 Magseed Magnetic Marker SystemEndomagnetics Ltd., · 2017
- Descendant · 3 generations on · 5 of its ownK210600 MOLLIMolli Surgical, Inc. · 2021
- Descendant · 4 generations on · 4 of its ownK223107 MOLLI 2Molli Surgical, Inc. · 2023
- Descendant · 5 generations on · 3 of its ownK231579 MOLLI 2Molli Surgical, Inc. · 2023 · Recalled
Showing 5 of 15 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 15 · See all- K153044Sentimag System, Sentimark Magnetic Marker SystermEndomagnetics Ltd., · 2016 · cites it directly13descendants
- K163541Magseed Magnetic Marker SystemEndomagnetics Ltd., · 2017 · 2 generations on12descendants
- K210600MOLLIMolli Surgical, Inc. · 2021 · 3 generations on5descendants
- K223107MOLLI 2Molli Surgical, Inc. · 2023 · 4 generations on4descendants
- K231579MOLLI 2Molli Surgical, Inc. · 2023 · 5 generations on3descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | K023694 | Bio-Mark Resorbable Biopsy Site Marker and Bio-Mark Permanent Biopsy Site Marker | Biopsy Sciences, LLC | 2003 | — |
| −5 | K051421 | Inter V Brand V-Mark Breast Biopsy Site Marker with Titanium Anchor | Medical Device Technologies, Inc. | 2005 | — |
| −4 | K053518 | Interv Brand V-Mark Breast Biopsy Site Marker with Titanium Anchor | Medical Device Technologies, Inc. | 2006 | — |
| −3 | K060769 | Hydromark Biopsy Site Marker | Biopsy Sciences, LLC | 2006 | — |
| −2 | K083006 | Biopsy Sciences, Inc., Hydromark Breast Biopsy Site Marker | Biopsy Sciences, LLC | 2009 | — |
| −1 | K090501 | Biopsy Sciences Hydromark Breast Biopsy Site Marker, Models 4005-02-15-T1… | Biopsy Sciences, LLC | 2009 | — |
| 0 (this device) | K120804 | Cianna Medical Tissue Marker and Delivery System | Cianna Medical | 2013 | — |
| +1 | K153044 | Sentimag System, Sentimark Magnetic Marker Systerm | Endomagnetics Ltd., | 2016 | — |
| +2 | K163541 | Magseed Magnetic Marker System | Endomagnetics Ltd., | 2017 | — |
| +3 | K210600 | MOLLI | Molli Surgical, Inc. | 2021 | — |
| +4 | K223107 | MOLLI 2 | Molli Surgical, Inc. | 2023 | — |
| +5 | K231579 | MOLLI 2 | Molli Surgical, Inc. | 2023 | 1 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2004 | 2 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2021 | 2 | 0 |
| 2022 | 1 | 0 |
| 2023 | 4 | 0 |
| 2024 | 3 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in PBY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new PBY device
- #1 K222643 Sirius Pintuition Seed, Sirius Pintuition…score 9.9 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K102506 | Mixed Media MarkerSummary page 1…Implantable Clip, 21 CFR 878.4300 DEVICE CLASSIFICATION: Class 11 PRODUCT CODE PBY PREDICATE DEVICES: Mixed Media Marker- K102506 TuMark Flex Tissue Marking System- KI 11692 H-ydromark (K09050 1)… | 2011 |
| * | K111692 | Tumark Flex for Mammotome,Tumark Flex for AtecSummary page 1…bstantially equivalent in intended use, principal of operation and technological characteristics to the Mixed Media Marker (K 102506), TuMark Flex Tissue Marking System (K 111692), and the H-ydromark (K09050 1). The Cianna Medical Tissue Marker differs from the predicates only in its intended implant durati… | 2011 |
| * | K090501 | Biopsy Sciences Hydromark Breast Biopsy Site Marker, Models 4005-02-15-T1…Summary page 1…TE DEVICES: Mixed Media Marker- K102506 TuMark Flex Tissue Marking System- KI 11692 H-ydromark (K09050 1) Substantially Equivalent To: The Cianna Medial Tissue Marker and Delivery System is substantially equivalent in intended use, p… | 2009 |
What descends from it? (15)
See all 152 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 2.5 years on median.
- 3 of the 20 ancestors have a recall of any class.
- Of its descendants, K153044 (Endomagnetics Ltd.,, 2016) has gone furthest, with 13 descendants of its own.
- 3 other devices also cite its predicate K102506.
How does its category compare?
All PBY devicesPBY Temporary Tissue Marker: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · PBY
1in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · PBY
Too few PBY 510(k)s in any year since 2007 to give a median.
Recalls per year · PBY
No recall names PBY since 2007.
Adverse event reports per year · PBY
1in 2024
MAUDE reports naming product code PBY, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 1 | — | 0 | 0 |
| 2017 | 2 | — | 0 | 1 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 0 |
| 2022 | 1 | — | 0 | 0 |
| 2023 | 1 | — | 0 | 1 |
| 2024 | 0 | — | 0 | 1 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Cianna Medical Tissue Marker is intended to be placed percutaneously in the breast to temporarily (< 30 days) mark a lumpectomy site intended for surgical removal. Using ultrasound or radiography imaging guidance, the Cianna Tissue Marker is located and surgically removed with the target tissue.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K120804 · printed Nov 6, 2026
Cite this page
510(k) Report. “K120804: Cianna Medical Tissue Marker and Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K120804
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026